MARLOWE JENNIFER (CSO, FA & Cardiac) sold 41.1% of their position (4.89K shares) of SOLID BIOSCIENCES INC. on the open market
Open‑market sale worth $13.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/5/2023ACC: 0000950170-23-068063
Officer· CSO, FA & Cardiac
Since Dec 2022
-4.89K
Net shares
Net seller
$13.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
11.89K acquired · 16.78K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.89K
Price / share
—
Trade value
—
% of position
New position
12/2/2023
0.00→11.89K
Common Stock
Direct
Shares
−4.89K
Price / share
$2.77
Trade value
$13.52K
% of position
41.1%
12/4/2023
11.89K→7K
Total
Net shares
+7K
Net value
-$13.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2023 | M · Option Exercise | +11.89K | — | — | New position | 0.00 | 11.89K |
| Common Stock Direct | 12/4/2023 | S · Sale | −4.89K | $2.77 | $13.52K | 41.1% | 11.89K | 7K |
| Total | +7K | -$13.52K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
11.89K shares
Shares
−11.89K
Strike price
Held after
35.67K
Exercisable
—
12/2/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock11.89K shares | 12/2/2023 | M · Option Exercise | −11.89K | — | 35.67K |